Growth Hormone Releasing Peptide
Ipamorelin
Selective GHRP for clean growth hormone axis research.
Complete guide to Ipamorelin in AustraliaPrices in AUD. Tax included.
Research Use Only: FOR LABORATORY RESEARCH USE ONLY. Not for human consumption, injection, or therapeutic use. All products are sold strictly as research chemicals. By purchasing, you confirm you are 18+ and agree to use products solely for legitimate research purposes.
Description
Ipamorelin is a selective growth hormone-releasing peptide (GHRP) that acts via the ghrelin/GHS-R1a receptor. It is widely preferred in research for its minimal off-target effects on cortisol, prolactin, and ACTH compared to earlier GHRPs.
Specifications
- SKU
- IPA-10MG
- Size
- 10 mg
- Form
- Lyophilised Powder
- Purity
- >99%
- Storage
- -20°C (lyophilised), 2-8°C (reconstituted)
- Shipping
- Australia Post — 3–5 business days
Research Summary
Studies show Ipamorelin stimulates GH release in a dose-dependent manner with high selectivity for the GH axis. Research demonstrates synergistic GH output when combined with GHRH analogues such as CJC-1295, with complementary effects on pulse frequency and amplitude.
Testing Protocol
- HPLC Purity Analysis
- Mass Spectrometry Identity Verification
- Endotoxin Screening (LAL Test)